Conflicting Data: While some clinical trials suggested a minor increase in risk, many large-scale "real-world" studies have found no statistically significant difference in pancreatitis risk when comparing GLP-1 users to those on other diabetes treatments
This can happen when medication is exposed to excessive heat , left in direct sunlight, or stored beyond its expiration date
You can also follow this general advice for managing side effects on GLP-1s: Eat smaller portions, more often, and more slowly Only eat when youre hungry, and stop when youre full Sip slowly on clear, cold drinks like water Avoid anything too sweet, spicy, fatty, or fried After eating, go for a gentle stroll in the fresh air The Possibility of a Temporary Weight Stall Tirzepatide is generally considered more effective, so when you switch from tirzepatide to semaglutide, you may experience an increase in your appetite and some rebound weight gain
For context, that puts the tablet broadly in the territory of the 2.4 mg weekly injection studied in STEP 1 (Wilding et al., 2021), which is the comparison most patients will reach for
